

![]() |
Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study |
|
Authors | ![]() | |
Published in | Journal of Acquired Immune Deficiency Syndromes. 2012, vol. 59, no. 1, p. 79-85 | |
Abstract | Persons from sub-Saharan Africa (SSA) are increasingly enrolled in the Swiss HIV Cohort Study (SHCS). Cohorts from other European countries showed higher rates of viral failure among their SSA participants. We analyzed long-term outcomes of SSA versus North Western European participants. | |
Keywords | Adult — Africa South of the Sahara/ethnology — African Continental Ancestry Group — Anti-HIV Agents/therapeutic use — CD4 Lymphocyte Count — Cohort Studies — European Continental Ancestry Group — Female — HIV Infections/drug therapy/ethnology/virology — Humans — Male — Middle Aged — Prospective Studies — Switzerland/epidemiology — Time Factors — Treatment Outcome — Viral Load/drug effects | |
Identifiers | PMID: 21937923 | |
Full text | ||
Structures | ||
Research group | VIH/SIDA (930) | |
Citation (ISO format) | STAEHELIN, Cornelia et al. Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study. In: Journal of Acquired Immune Deficiency Syndromes, 2012, vol. 59, n° 1, p. 79-85. https://archive-ouverte.unige.ch/unige:31627 |